东胜创新携手Fluidigm开启单细胞技术巡回讲座
浏览次数:5332 发布日期:2014-9-30
来源:本站 本站原创,转载请注明出处

The Biography of the two speakers are as follows:
Xiangxu Kong (孔祥旭),Ph.D
Now Doctor Kong is the single cell biology specialist of Fluidigm, working closely with customers in Pacific Asia and Latin America, very experienced in single-cell related research and diagnostics.
Dongxia Lin, Ph.D
Doctor Lin Dongxia is currently a Postdoctoral Research Scholar in Human Immune Monitoring Center at Stanford Univeristy. Lin is in the lab which has the Second and 22nd CyTOF of the world. In the past 3-years, Lin is working on many frontier fields with CyTOF mass cytometry. Using this cutting-edge multi-parameter single-cell technology, she has successfully finished three major projects, including biomarker prediction for autoimmune disease treatment; influenza vaccine efficacy evaluation and antigen specific T cell response in transplant patients. These results were published in several well-known journals and presented on international conferences in Cold Spring Harbor, Hawaii and Canada before.
本次单细胞技术巡回讲座首站将在上海举行,陆续会在北京,苏州等城市展开,活动通知及时更新,届时期待您的光临指导!
欲知更多详情,请通过以下方式联系我们:

致力于生命科学最前沿技术——东胜创新分子影像事业部
客服邮箱:news@eastwin.com.cn
销售热线:021-61374481
欢迎您和我们一起见证生命科学的成长!